XML 47 R19.htm IDEA: XBRL DOCUMENT v2.4.0.8
Restatement Of Financial Statements
12 Months Ended
Jun. 30, 2013
Restatement Of Financial Statements  
NOTE 13 - RESTATEMENT OF FINANCIAL STATEMENTS

The Company has restated its Balance Sheet as of June 30, 2013, its Statement of Operations for the year ended June 30, 2013, its Statement of Cash Flows for the year ended June 30, 2013, and it’s Statements of Stockholders’ Equity to account for an additional $100,000 of convertible debt from Asus Global Holdings Inc. The funds were wired directly to an officer of the Company and did not pass through the Company’s bank account. The Company recalculated the derivative liability related to the additional convertible debt outstanding. The terms of the additional convertible debt are the same as other convertible debt from Asus Global Holdings.

 

The following are previously recorded and restated balances as of June 30, 2013 and for the year ended June 30, 2013.

 

NANO LABS CORP.
BALANCE SHEETS

 

    June 30, 2013  
    Originally              
    Reported     Restated     Difference  
ASSETS                  
CURRENT ASSETS                  
Cash   $ 28,196     $ 28,196       -  
                         
Total current assets     28,196       28,196       -  
                         
Total Assets   $ 28,196     $ 28,196       -  
                         
LIABILITIES AND STOCKHOLDERS' DEFICIT                        
CURRENT LIABILITIES:                        
 Accounts payable   $ 7,765     $ 7,765       -  
 Related party payables     -       -       -  
 Notes payable     -       -       -  
 Convertible notes payable     666,000       766,000       (100,000 )
 Derivative Liability     8,223,786       9,448,441       (1,224,655 )
 Accrued interest payable     -       -       -  
      8,897,551       10,222,206       (1,324,655 )
                         
Total current liabilities     8,897,551       10,222,206       (1,324,655 )
                         
STOCKHOLDERS' DEFICIT                        
                         
Preferred stock: $0.001 par value; 10,000,000 shares authorized;                        
none issued or outstanding at June 30, 2013 and 2012,          respectively.     -       -       -  
Common stock: $0.001 par value; 500,000,000 shares authorized;                        
103,125,000 and 179,125,000 shares issued and outstanding                        
at June 30, 2013 and 2012, respectively.     103,125       103,125       -  
Common stock issuable     101,000       101,000       -  
Additional paid-in capital     381,356       381,356       -  
Accumulated deficit     (9,454,836 )     (10,779,491 )     1,324,655  
Total stockholders' deficit     (8,869,355 )     (10,194,010 )     1,324,655  
                         
Total liabilities and stockholders' deficit   $ 28,196     $ 28,196       -  

 

The accompanying notes are an integral part of these financial statements.

 

NANO LABS CORP.
STATEMENTS OF OPERATIONS

 

    For the year ended June 30, 2013  
   

Originally

Reported

    Restated     Difference  
Sales   $ -     $ -       -  
Cost of goods sold     -       -       -  
Gross Margin     -       -       -  
                         
Operating Expenses                        
Consulting     264,116       264,116       -  
General and administrative     122,010       222,010       100,000  
Professional Fees     46,833       46,833       -  
Travel     93,831       93,831       -  
Wages     86,518       86,518       -  
Total operating expenses     613,308       713,308       100,000  
                         
Loss from Operations     (613,308 )     (713,308 )     (100,000 )
                         
Other (Income) Expenses                        
Interest expense- derivative     (8,223,786 )     (9,448,441 )     1,224,655  
Loss on sale to subsidiary     (32,261 )     (32,261 )     -  
Other (income) expenses     (8,256,047 )     (9,480,702 )     1,224,655  
                         
Loss before Income Taxes     (8,869,355 )     (10,194,010 )     (1,324,655 )
                         
Provision for income tax     -       -       -  
                         
Net Loss from continuing operations   $ (8,869,355 )   $ (10,194,010 )     (1,324,655 )
                         
Discontinued Operations:                        
Income from discontinued operations     -       -       -  
                         
Net Loss   $ (8,869,355 )   $ (10,194,010 )     (1,324,655 )
                         
Net income (loss) per common share- basic and diluted   $ (0.08 )   $ (0.10 )     0.02  
                         
Weighted average common shares outstanding-                        
basic and diluted     107,081,164       107,081,164       -  

 

 The accompanying notes are an integral part of these financial statements.

 

NANO LABS CORP.
STATEMENTS OF CASH FLOWS

 

    For the Year Ended June 30, 2013  
   

Originally

Reported

    Restated     Difference  
CASH FLOWS FROM OPERATING ACTIVITIES:                  
Net loss   $ (8,869,355 )   $ (10,194,010 )     1,324,655  
Adjustments to reconcile net loss to net cash                        
used by operating activities:                        
Derivative interest     8,223,786       9,448,441       (1,224,655 )
Debt forgiveness     209,015       209,015       -  
Changes in operating assets and liabilities:                        
Discontinued operations     -       -       -  
Related party payables     (200 )     (200 )     -  
Accounts payable and accrued expenses     (154,027 )     (154,027 )     -  
NET CASH USED IN OPERATING ACTIVITIES     (590,781 )     (690,781 )     100,000  
                         
CASH FLOWS FROM FINANCING ACTIVITIES:                        
Repayment of notes payable     (47,023 )     (47,023 )     -  
Proceed from convertible notes payable     666,000       766,000       (100,000 )
NET CASH PROVIDED BY FINANCING ACTIVITIES     618,977       718,977       (100,000 )
                         
NET CHANGE IN CASH     28,196       28,196       -  
                         
Cash at beginning of the period     -       -       -  
                         
Cash at end of the period   $ 28,196     $ 28,196       -  
                         
SUPPLEMENTAL DISCLOSURE OF                        
CASH FLOWS INFORMATION:                        
                         
Interest paid   $ -     $ -       -  
Income tax paid   $ -     $ -       -